🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Corcept Therapeutics Incorporated

CORT Healthcare
$41.57 $-0.34 (-0.80%)
Market Cap: $4.42 B
Gurus Holding
8
Popularity Rank
#882
% of Shares Held
6.77%
Net Activity (Q4 2025)
-$31.81 M

Guru Ownership Trend

Guru Analysis for Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Incorporated (CORT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $299.59 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $31.81 M net outflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Cliff Asness reduced exposure by 41.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$2.27 M
Total Buy Value
New Buys 2
Additions 0
-$34.07 M
Total Sell Value
Reductions 5
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
5
Net Buyers
2

FAQs for Corcept Therapeutics Incorporated (CORT)

Major holders include Renaissance Technologies (RenTech) ($200.4 M), Cliff Asness ($30.9 M), Ray Dalio ($9.71 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 7.21 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $31.81 M, with 2 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 5 managers trimmed their positions, while 0 fully exited CORT. The total reported sell value was $34.07 M.

Yes, 2 managers opened new positions in CORT, and 0 increased their existing holdings. The total reported buy value was $2.27 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.31% Reduce -5.4% 5,758,528 $200.4 M Q4 2025
0.02% Reduce -41.1% 887,861 $30.9 M Q4 2025
0.04% Reduce -8.8% 279,000 $9.71 M Q4 2025
0.06% Reduce -1.2% 166,562 $5.8 M Q4 2025
0.01% New Buy 58,081 $2.02 M Q4 2025
0.26% 31,500 $1.1 M Q4 2025
0.00% Reduce -0.1% 17,352 $603,850 Q4 2025
0.00% New Buy 7,068 $245,966 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form